Oppenheimer Asset Management Inc. cut its stake in Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 36.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,753 shares of the company’s stock after selling 5,125 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Stevanato Group were worth $214,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of the stock. Hancock Whitney Corp lifted its position in Stevanato Group by 4.8% in the first quarter. Hancock Whitney Corp now owns 11,482 shares of the company’s stock worth $234,000 after buying an additional 528 shares during the last quarter. Van Berkom & Associates Inc. lifted its position in Stevanato Group by 33.3% in the first quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company’s stock worth $49,000 after buying an additional 600 shares during the last quarter. First Bank & Trust lifted its position in Stevanato Group by 6.2% in the second quarter. First Bank & Trust now owns 16,142 shares of the company’s stock worth $394,000 after buying an additional 944 shares during the last quarter. Whittier Trust Co. bought a new stake in Stevanato Group in the first quarter worth $27,000. Finally, Twin Tree Management LP bought a new stake in Stevanato Group in the first quarter worth $29,000.
Stevanato Group Stock Up 2.0%
NYSE:STVN opened at €25.45 on Monday. Stevanato Group S.p.A. has a twelve month low of €17.49 and a twelve month high of €28.00. The company has a market cap of $7.71 billion, a price-to-earnings ratio of 47.12, a price-to-earnings-growth ratio of 2.37 and a beta of 0.56. The stock has a fifty day simple moving average of €25.17 and a 200-day simple moving average of €24.14. The company has a current ratio of 1.79, a quick ratio of 1.22 and a debt-to-equity ratio of 0.25.
Analyst Ratings Changes
Read Our Latest Report on STVN
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Stories
- Five stocks we like better than Stevanato Group
- Insider Trading – What You Need to Know
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Caterpillar Stock Could Top $650 by Year’s End
- What is the NASDAQ Stock Exchange?
- ServiceNow’s 5-for-1 Split Is a Signal for Investors to Buy
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
